Is there a role of Gabapentin as Add-on therapy in Dystonic Cerebral Palsy?
Phase 3
- Conditions
- Health Condition 1: G808- Other cerebral palsy
- Registration Number
- CTRI/2018/12/016689
- Lead Sponsor
- Jaslok Hospital and Research Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1) Diagnosed case of dystonic cerebral palsy
2) Participants on stable medication for tone for last 4 weeks
3) Participants on stable rehabilitation programme for last 6 weeks
4) Participants are able to swallow the drug
5) Parents/ caregivers are able to understand/comply with the study trial requirements
Exclusion Criteria
1) Known allergy to Gabapentin and/or its ingredients
2) Age less than 2 years and greater than 18 years at the enrollment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Barry Albright Dystonia Scale <br/ ><br>Movement Disorder- Childhood Rating ScaleTimepoint: 0, 12 and 24 weeks
- Secondary Outcome Measures
Name Time Method Monitoring side effectsTimepoint: 4 weeks, 12 weeks and 24 weeks;PEDsQLTimepoint: Day 0, 12 weeks and 24 weeks